Chase Pharmaceuticals Corporation, an affiliate of Allergan
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Chase Pharmaceuticals Corporation, an affiliate of Allergan sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Chase Pharmaceuticals Corporation, an affiliate of Allergan: 3 sponsored US clinical trials, none currently recruiting.
Chase Pharmaceuticals Corporation, an affiliate of Allergan sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Dementia of Alzheimer's Type, with 1 trials.
Upper-quartile sponsor footprint
Chase Pharmaceuticals Corporation, an affiliate of Allergan sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type
NCT02549196
Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07
NCT02434666
A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia
NCT02185053
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
Therapeutic Areas
How the Chase Pharmaceuticals Corporation, an affiliate of Allergan early-phase archive is shaped
3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Dementia of Alzheimer's Type (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Chase Pharmaceuticals Corporation, an affiliate of Allergan: archived-pipeline peers nationwide
Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Chase Pharmaceuticals Corporation, an affiliate of Allergan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 archived trials
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
- 3EO Health · 0% recruiting · 2 trials
Related
What to do with this Chase Pharmaceuticals Corporation, an affiliate of Allergan page
3 registered trials is a research-attention snapshot, not an endorsement of Chase Pharmaceuticals Corporation, an affiliate of Allergan or any single study.
- None of Chase Pharmaceuticals Corporation, an affiliate of Allergan's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Dementia of Alzheimer's Type is the condition Chase Pharmaceuticals Corporation, an affiliate of Allergan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dementia of Alzheimer's Type trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Chase Pharmaceuticals Corporation, an affiliate of Allergan pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.